Compare Five9 Inc (FIVN) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five9 Inc vs Altria Group Inc — how do they compare? Five9 Inc trades at $34.75 (market cap $2.63B), while Altria Group Inc trades at $71.23 (market cap $115.85B). The key difference: Altria Group Inc is far larger — about 44× Five9 Inc's market cap, and Altria Group Inc pays a 6.4% dividend while Five9 Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Five9 Inc for 72 Days and Altria Group Inc for 154 Days on average.
| FIVN | MO | |
|---|---|---|
Market Cap | $2.63B | $115.85B |
Volume | 1,864,393 | 6,934,962 |
Sector | Technology | Consumer Staples |
52-Week High | $38.65 | $74.92 |
52-Week Low | $13.61 | $54.72 |
Typical Hold Time | 72 Days | 154 Days |
Enterprise Value | $2.78B | $138.06B |
Dividend Yield | — | 6.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five9 (FIVN) trades at $33.78, up 1.47% with strong analyst support (61% buy ratings) and a $34 consensus target. The stock shows bullish technical momentum above key support at $33, supported by consistent earnings beats and accelerating AI revenue growth (78% YoY in Q2 2026). Revenue reached $1.15B in 2025 with improving profitability (net margin 3.43%), though valuation remains elevated at P/E 49.7.
Outlook remains positive with AI-driven subscription growth and raised guidance, but risks include high valuation sensitivity and insider selling. The stock's proximity to its 52-week high suggests near-term consolidation potential, while fundamental improvement supports long-term upside if execution continues.
Altria Group (MO) trades at $69.39, up 1.22% today, with a bullish technical signal from moving averages. The stock shows strong profitability with a 39% net income margin and a 6.6% dividend yield, though recent earnings have been mixed with two misses in the last four quarters. Cash flow improved in 2025 with net cash flow of $1.33 billion, but the balance sheet carries negative equity of -$2.24 billion due to high liabilities.
The outlook is balanced: analyst consensus is bullish with a $69.71 price target, but risks include regulatory pressures on tobacco, declining margins, and high debt. The dividend appears sustainable from cash flow, yet negative equity and business shrinkage pose long-term concerns for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
